Fredun Pharmaceuticals Ltd: Financial Statements & Historical Data

COMPANY FINANCIAL DATA

Reported figures at a glance

Stored figures, not live quotes. Price record: 29 September 2026, 11:18 pm +05:30. Financial reporting periods are shown in the tables below.

Stored share price1,392₹ per share

Reported P/E51.8Times

Book value per share170₹ per share

Reported ROCE21.5 %%

Data sources and reporting basis

Sources: Company data source. Check the company filings linked by the source for the reporting basis and exceptional items.

Different tables can have different reporting dates and accounting bases. Verify the company filings before comparing figures. Missing data is not treated as zero.

How Getaka handles sources, dates and corrections. Page revision dates describe the page, not the age of every financial figure.

Stored market and accounting figures

Price record: 29 September 2026, 11:18 pm +05:30. Not a live quote.

Measure	Stored figure
Market Cap	2,301 Cr.
Current Price	1,392
High / Low	1,600/427
Stock P/E	51.8
Book Value	170
Dividend Yield	0.02 %
ROCE	21.5 %
ROE	15.8 %
Face Value	10.0

Market cap is in ₹ crore; prices and per-share values are in ₹. P/E is a multiple; yield, ROCE and ROE are percentages. Book value is an accounting figure, not an estimate of the share's investment value.

Competitors

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
Fredun Pharmaceuticals Ltd	2,301 Cr.	1,392	1,600/427	51.8	170	0.02 %	21.5 %	15.8 %	10.0
Panacea Biotec Ltd	2,290 Cr.	375	648/292		136	0.00 %	2.43 %	2.42 %	1.00
Beta Drugs Ltd	2,289 Cr.	2,065	2,808/990	50.2	241	0.00 %	19.2 %	18.8 %	10.0
Venus Remedies Ltd	2,284 Cr.	1,711	2,044/424	19.7	497	0.58 %	20.7 %	15.6 %	10.0
Syncom Formulations (India) Ltd	2,461 Cr.	26.2	26.6/10.2	29.0	4.39	0.38 %	24.8 %	17.6 %	1.00
Industry Average	17,958.89 Cr	1,272.73		56.24	211.60	0.38%	26.16%	16.59%	6.06

All Competitor Stocks of Fredun Pharmaceuticals Ltd

FINANCIALS

Quarterly performance

Compare sales, expenses, operating profit and net profit on one chart, across the same reporting quarters.

Sales, expenses & profits

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Supporting financial tableAll reported figures · use a chart icon for peer comparison

Quarterly Chart Table

Metric	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	62	82	87	118	79	107	103	167	120	145	161	213	228
Expenses	54	72	76	107	68	93	89	150	103	123	135	184	195
Operating Profit	8	10	11	11	10	14	13	17	17	22	26	29	33
OPM %	12%	12%	12%	9%	13%	13%	13%	10%	14%	15%	16%	14%	14%
Other Income	0	0	0	0	0	0	0	0	0	0	0	0	0
Interest	3	3	4	4	4	5	5	8	7	8	11	14	9
Depreciation	1	1	1	1	1	1	1	1	1	2	2	3	4
Profit before tax	4	6	6	6	6	8	7	8	9	13	14	12	21
Tax %	41%	32%	27%	13%	25%	44%	25%	12%	25%	25%	25%	4%	36%
Net Profit	2	4	4	5	4	4	5	7	7	10	10	11	13
EPS in Rs	1.75	2.79	2.99	3.59	2.91	3.01	3.75	4.98	4.77	6.85	6.51	6.75	7.98

Last Updated: September 29, 2026, 6:39 am

FINANCIALS

Annual performance

Compare sales, expenses, operating profit and net profit across financial years. Trailing figures remain in the table.

Sales, expenses & profits

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Earnings per share

₹ per share

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

Supporting financial tableAll reported figures · use a chart icon for peer comparison

Profit & Loss Chart Table

Last Updated: September 29, 2026, 11:18 pm

Metric	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	21	25	42	57	60	97	113	134	222	275	348	454	635	748
Expenses	20	24	38	53	54	87	104	126	208	247	310	401	544	637
Operating Profit	1	2	4	3	6	10	8	8	14	28	38	53	91	111
OPM %	7%	7%	9%	6%	10%	11%	7%	6%	6%	10%	11%	12%	14%	15%
Other Income	0	0	1	2	0	0	1	1	2	2	1	2	4	0
Interest	1	1	2	2	2	3	4	4	5	9	14	22	39	41
Depreciation	1	1	1	1	1	1	2	2	2	3	4	4	8	10
Profit before tax	0	1	2	2	3	6	2	3	9	18	21	28	48	59
Tax %	47%	52%	42%	36%	34%	28%	24%	37%	26%	38%	27%	26%	30%
Net Profit	0	0	1	1	2	4	2	2	6	11	16	21	33	44
EPS in Rs	1.02	0.37	1.51	2.01	1.70	3.72	1.58	1.68	4.77	7.95	11.08	14.65	20.25	28.09
Dividend Payout %	0%	0%	13%	10%	12%	6%	14%	14%	5%	3%	2%	2%	1%

YoY Net Profit Growth

Year	2016-2017	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024	2024-2025	2025-2026
YoY Net Profit Growth (%)	0.00%	100.00%	100.00%	-50.00%	0.00%	200.00%	83.33%	45.45%	31.25%	57.14%
Change in YoY Net Profit Growth (%)	0.00%	100.00%	0.00%	-150.00%	50.00%	200.00%	-116.67%	-37.88%	-14.20%	25.89%

Fredun Pharmaceuticals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2016-2017 to 2025-2026.

Growth

Compounded Sales Growth
10 Years:	34%
5 Years:	32%
3 Years:	27%
TTM:	36%

Compounded Profit Growth
10 Years:	54%
5 Years:	61%
3 Years:	49%
TTM:	35%

Stock Price CAGR
10 Years:	Not available
5 Years:	41%
3 Years:	4%
1 Year:	64%

Return on Equity
10 Years:	13%
5 Years:	13%
3 Years:	15%
Last Year:	16%

Last Updated: September 5, 2025, 3:30 pm

FINANCIALS

Balance sheet

Compare reserves and borrowings across the same financial years. Reserves are an accounting balance, not available cash.

Reserves & borrowings

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Supporting financial tableAll reported figures · use a chart icon for peer comparison

Balance Sheet Data Table

Last Updated: September 29, 2026, 11:18 pm

Month	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	2	2	2	3	4	4	4	4	5	5	5	5
Reserves	0	1	2	19	35	37	39	64	92	117	137	273
Borrowings	9	16	21	10	19	35	40	53	87	106	166	222
Other Liabilities	11	24	30	47	47	65	79	66	74	81	179	141
Total Liabilities	23	43	56	79	105	141	162	187	257	308	487	642
Fixed Assets	8	15	16	16	31	31	30	32	39	47	53	118
CWIP	1	0	4	11	0	0	0	0	0	0	0	0
Investments	0	0	0	0	0	0	0	0	0	1	2	2
Other Assets	14	29	36	52	74	110	131	155	218	260	433	522
Total Assets	23	43	56	79	105	141	162	187	257	308	487	642

FINANCIALS

Cash generation

Compare operating cash and free cash flow across reported periods. Negative values remain visible.

Operating & free cash flow

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Supporting financial tableAll reported figures · use a chart icon for peer comparison

Cash Flows

Month	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity +	2	3	4	17	1	-11	0	-2	-14	-0	-21	16
Cash from Investing Activity +	-3	-6	-7	-8	-5	-1	-1	-4	-9	-8	-6	-74
Cash from Financing Activity +	1	3	3	-8	4	14	-1	7	25	6	26	122
Net Cash Flow	0	1	-1	1	0	2	-2	1	1	-2	-1	65
Free Cash Flow	-1	-3	-3	9	-4	-12	-1	-7	-24	-8	-27	-57
CFO/OP	108%	85%	117%	303%	8%	-128%	2%	-17%	-52%	-1%	-43%	18%

Free cash flowAll reported figures · use a chart icon for peer comparison

Free Cash Flow Table

Free cash flow reported in the stored cash-flow statement (₹ Cr)
Period	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Free Cash Flow	-1.00	-3.00	-3.00	9.00	-4.00	-12.00	-1.00	-7.00	-24.00	-8.00	-27.00	-57.00

This table and the chart use the Free Cash Flow row from the same stored cash-flow statement. Free cash flow generally measures operating cash flow after capital expenditure; check the source definition and reporting basis. It is not operating profit minus borrowings.

Financial efficiency feed. Source: www.screener.in. Check the source for the accounting basis. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

FINANCIALS

Financial & business efficiency

Compare collection, inventory, payment and working-capital cycles together in days. Returns on capital and equity follow in a separate percentage chart.

Working capital

Days

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Returns on capital & equity

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

Supporting financial tableAll reported figures · use a chart icon for peer comparison

Financial Efficiency Data Table

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Debtor Days	59	75	98	131	94	67	126	112	148	46	68	142
Inventory Days	107	102	140	68	170	249	227	242	96	264	246	265
Days Payable	152	167	221	224	360	205	208	215	101	104	88	160
Cash Conversion Cycle	14	11	17	-24	-96	110	145	139	144	205	225	247
Working Capital Days	-44	-54	-44	-39	42	66	65	116	126	97	92	76
ROCE %	14%	14%	25%	18%	16%	21%	10%	10%	13%	18%	17%	19%

FINANCIALS

Ownership trends

Compare ownership groups across the same reporting dates. Shareholder counts appear separately below.

Shareholding comparison

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Shareholder count

Shareholders

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

Supporting financial tableAll reported figures · use a chart icon for peer comparison

Shareholding Pattern

Month	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Jul 2026
Promoters	49.16%	49.17%	49.17%	48.93%	48.93%	48.93%	48.93%	48.93%	43.06%	44.17%	44.57%	44.57%
FIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.01%	0.46%	1.06%	1.06%	1.06%
DIIs	1.60%	1.60%	1.60%	1.59%	1.59%	1.59%	1.59%	1.61%	3.48%	2.83%	2.94%	2.94%
Public	49.24%	49.24%	49.23%	49.47%	49.47%	49.47%	49.49%	49.46%	53.00%	51.94%	51.45%	51.43%
No. of Shareholders	6,837	7,507	7,511	8,018	8,121	7,976	7,906	8,120	8,765	8,338	8,903	9,598

This stock is not held by any mutual fund.

Alternate ratio feed. Source: www.way2wealth.com. The accounting basis and ratio definitions require verification against the source. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

FINANCIALS

Ratios from the alternate data feed

Related measures share a chart and a common unit. Use the dated figures below to examine any change.

Profitability ratios

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Liquidity ratios

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Distributions & retention

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Interest coverage

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Valuation multiples

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Supporting financial tableAll reported figures · use a chart icon for peer comparison

Key Financial Ratios

Month	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
FaceValue	10.00	10.00	10.00	10.00	10.00
Basic EPS (Rs.)	44.83	33.66	24.13	11.28	5.05
Diluted EPS (Rs.)	44.83	33.32	22.93	11.28	5.05
Cash EPS (Rs.)	53.49	41.32	30.04	19.16	10.07
Book Value[Excl.RevalReserv]/Share (Rs.)	299.47	258.49	212.64	153.54	107.96
Book Value[Incl.RevalReserv]/Share (Rs.)	299.47	258.49	212.64	153.54	107.96
Dividend / Share (Rs.)	0.70	0.70	0.70	0.70	0.70
Revenue From Operations / Share (Rs.)	961.13	740.88	606.04	506.38	335.60
PBDIT / Share (Rs.)	116.69	82.78	65.31	34.80	26.41
PBIT / Share (Rs.)	107.27	74.70	59.11	29.93	21.39
PBT / Share (Rs.)	59.87	45.65	38.63	19.40	8.04
Net Profit / Share (Rs.)	44.07	33.25	23.84	14.29	5.05
PBDIT Margin (%)	12.14	11.17	10.77	6.87	7.86
PBIT Margin (%)	11.16	10.08	9.75	5.91	6.37
PBT Margin (%)	6.22	6.16	6.37	3.83	2.39
Net Profit Margin (%)	4.58	4.48	3.93	2.82	1.50
Return on Networth / Equity (%)	14.71	12.86	11.21	9.30	4.67
Return on Capital Employeed (%)	31.78	24.93	17.72	11.71	11.35
Return On Assets (%)	4.27	5.07	4.20	3.38	1.24
Long Term Debt / Equity (X)	0.06	0.10	0.50	0.61	0.67
Total Debt / Equity (X)	1.18	0.86	0.89	0.77	0.92
Asset Turnover Ratio (%)	1.14	1.23	1.24	1.29	0.90
Current Ratio (X)	1.31	1.54	2.04	2.07	1.50
Quick Ratio (X)	0.57	0.49	0.62	1.44	0.72
Inventory Turnover Ratio (X)	2.19	1.75	2.51	3.11	1.71
Dividend Payout Ratio (NP) (%)	1.58	2.09	2.88	4.89	13.30
Dividend Payout Ratio (CP) (%)	1.30	1.68	2.28	3.65	6.67
Earning Retention Ratio (%)	98.42	97.91	97.12	95.11	86.70
Cash Earning Retention Ratio (%)	98.70	98.32	97.72	96.35	93.33
Interest Coverage Ratio (X)	2.46	2.85	3.19	3.30	2.53
Interest Coverage Ratio (Post Tax) (X)	1.93	2.14	2.16	2.36	1.76
Enterprise Value (Cr.)	477.16	441.23	435.36	456.41	223.45
EV / Net Operating Revenue (X)	1.05	1.27	1.59	2.03	1.67
EV / EBITDA (X)	8.66	11.34	14.71	29.59	21.21
MarketCap / Net Operating Revenue (X)	0.69	0.96	1.28	1.81	1.38
Retention Ratios (%)	98.41	97.90	97.11	95.10	86.69
Price / BV (X)	2.23	2.77	3.66	5.96	4.29
Price / Net Operating Revenue (X)	0.69	0.96	1.28	1.81	1.38
EarningsYield	0.06	0.04	0.03	0.01	0.01